 Soumya Pandey
Concepts (123)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Purpura, Thrombotic Thrombocytopenic | 2 | 2018 | 15 | 1.000 |
Why?
| | Hematopoietic Stem Cells | 2 | 2018 | 180 | 0.980 |
Why?
| | Lymphohistiocytosis, Hemophagocytic | 1 | 2025 | 30 | 0.890 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2023 | 38 | 0.810 |
Why?
| | HLA Antigens | 2 | 2025 | 55 | 0.810 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2025 | 202 | 0.800 |
Why?
| | Histoplasmosis | 1 | 2023 | 48 | 0.790 |
Why?
| | Graft Rejection | 2 | 2025 | 166 | 0.760 |
Why?
| | Leukapheresis | 2 | 2018 | 18 | 0.680 |
Why?
| | Epidural Neoplasms | 1 | 2019 | 4 | 0.630 |
Why?
| | Spinal Cord Compression | 1 | 2019 | 12 | 0.630 |
Why?
| | Blood Coagulation | 2 | 2017 | 64 | 0.620 |
Why?
| | HIV Infections | 1 | 2023 | 394 | 0.600 |
Why?
| | Isoantibodies | 1 | 2019 | 28 | 0.590 |
Why?
| | Epitopes | 1 | 2019 | 62 | 0.580 |
Why?
| | Blood Platelets | 2 | 2017 | 239 | 0.570 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 101 | 0.570 |
Why?
| | Clinical Laboratory Techniques | 1 | 2018 | 28 | 0.560 |
Why?
| | Blood Component Removal | 1 | 2018 | 17 | 0.560 |
Why?
| | Plasma Exchange | 2 | 2015 | 25 | 0.550 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 122 | 0.540 |
Why?
| | Tissue Donors | 1 | 2019 | 126 | 0.540 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2017 | 39 | 0.540 |
Why?
| | Blood Grouping and Crossmatching | 1 | 2017 | 5 | 0.530 |
Why?
| | Kidney Transplantation | 1 | 2019 | 199 | 0.500 |
Why?
| | Decision Making | 1 | 2019 | 273 | 0.500 |
Why?
| | Aspirin | 1 | 2017 | 122 | 0.500 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 123 | 0.500 |
Why?
| | Factor VIII | 2 | 2024 | 22 | 0.490 |
Why?
| | Carcinoma, Signet Ring Cell | 1 | 2016 | 14 | 0.480 |
Why?
| | Multiple Myeloma | 5 | 2019 | 3013 | 0.470 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2017 | 211 | 0.470 |
Why?
| | Heparin | 1 | 2015 | 88 | 0.460 |
Why?
| | Hemoglobins, Abnormal | 1 | 2015 | 4 | 0.450 |
Why?
| | Thrombocytopenia | 1 | 2015 | 93 | 0.450 |
Why?
| | Erythrocyte Transfusion | 1 | 2015 | 52 | 0.440 |
Why?
| | ADAM Proteins | 1 | 2014 | 21 | 0.430 |
Why?
| | Bordetella pertussis | 1 | 2013 | 3 | 0.420 |
Why?
| | Whooping Cough | 1 | 2013 | 11 | 0.420 |
Why?
| | Anemia, Sickle Cell | 1 | 2015 | 101 | 0.410 |
Why?
| | Lymphocytes | 1 | 2013 | 146 | 0.390 |
Why?
| | Partial Thromboplastin Time | 1 | 2012 | 14 | 0.390 |
Why?
| | Prothrombin Time | 1 | 2012 | 18 | 0.390 |
Why?
| | Cell Nucleus | 1 | 2013 | 189 | 0.390 |
Why?
| | Glycoproteins | 1 | 2012 | 123 | 0.370 |
Why?
| | Paraproteinemias | 1 | 2012 | 72 | 0.370 |
Why?
| | Humans | 19 | 2025 | 52441 | 0.360 |
Why?
| | Male | 9 | 2025 | 26874 | 0.280 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 2 | 2019 | 108 | 0.270 |
Why?
| | Immunophenotyping | 2 | 2025 | 115 | 0.250 |
Why?
| | Adult | 6 | 2019 | 14205 | 0.250 |
Why?
| | Blood Transfusion | 2 | 2017 | 126 | 0.240 |
Why?
| | Female | 8 | 2025 | 28277 | 0.240 |
Why?
| | Immunogenetics | 1 | 2025 | 3 | 0.240 |
Why?
| | Histocompatibility Testing | 1 | 2025 | 14 | 0.230 |
Why?
| | Phagocytosis | 1 | 2025 | 54 | 0.230 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1028 | 0.230 |
Why?
| | Organ Transplantation | 1 | 2025 | 49 | 0.220 |
Why?
| | Retrospective Studies | 4 | 2018 | 6694 | 0.220 |
Why?
| | Hemophilia A | 1 | 2024 | 26 | 0.210 |
Why?
| | Histoplasma | 1 | 2023 | 24 | 0.200 |
Why?
| | Bone Marrow | 1 | 2025 | 354 | 0.200 |
Why?
| | Young Adult | 3 | 2019 | 4346 | 0.190 |
Why?
| | Aged | 4 | 2019 | 10242 | 0.190 |
Why?
| | Middle Aged | 5 | 2019 | 13133 | 0.190 |
Why?
| | Hemorrhage | 2 | 2024 | 225 | 0.170 |
Why?
| | Child | 3 | 2025 | 7194 | 0.160 |
Why?
| | Sarcoma, Myeloid | 1 | 2019 | 20 | 0.160 |
Why?
| | Autoantibodies | 2 | 2024 | 118 | 0.150 |
Why?
| | Hematocrit | 1 | 2018 | 42 | 0.140 |
Why?
| | Infant | 2 | 2025 | 3709 | 0.140 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2018 | 60 | 0.140 |
Why?
| | Antigens, CD34 | 1 | 2018 | 73 | 0.140 |
Why?
| | Flow Cytometry | 2 | 2016 | 396 | 0.140 |
Why?
| | Medical Waste | 1 | 2017 | 2 | 0.140 |
Why?
| | Cell Aggregation | 1 | 2017 | 6 | 0.140 |
Why?
| | Preoperative Care | 1 | 2019 | 173 | 0.140 |
Why?
| | Platelet Count | 1 | 2017 | 78 | 0.130 |
Why?
| | Lymphoma | 1 | 2018 | 71 | 0.130 |
Why?
| | Lymphoma, Follicular | 1 | 2017 | 27 | 0.130 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 47 | 0.130 |
Why?
| | Risk | 1 | 2017 | 315 | 0.130 |
Why?
| | Fibrosis | 1 | 2017 | 198 | 0.120 |
Why?
| | Antibodies | 1 | 2016 | 144 | 0.120 |
Why?
| | Bone Marrow Transplantation | 1 | 2016 | 110 | 0.120 |
Why?
| | Adolescent | 2 | 2019 | 6713 | 0.120 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 234 | 0.120 |
Why?
| | Hemoglobin J | 1 | 2015 | 3 | 0.110 |
Why?
| | Hemoglobin, Sickle | 1 | 2015 | 5 | 0.110 |
Why?
| | Hemoglobin C | 1 | 2015 | 6 | 0.110 |
Why?
| | Blood Donors | 1 | 2015 | 21 | 0.110 |
Why?
| | Logistic Models | 1 | 2017 | 930 | 0.110 |
Why?
| | Chylothorax | 1 | 2014 | 18 | 0.110 |
Why?
| | Incidence | 1 | 2017 | 1096 | 0.110 |
Why?
| | Reproducibility of Results | 1 | 2017 | 1223 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 182 | 0.100 |
Why?
| | Fibrinogen | 1 | 2012 | 31 | 0.100 |
Why?
| | Prognosis | 1 | 2018 | 2100 | 0.100 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 248 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2014 | 318 | 0.090 |
Why?
| | Combined Modality Therapy | 1 | 2014 | 641 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 600 | 0.090 |
Why?
| | Reference Values | 1 | 2012 | 316 | 0.090 |
Why?
| | Arkansas | 1 | 2017 | 2013 | 0.090 |
Why?
| | Leishmaniasis, Visceral | 1 | 2010 | 2 | 0.080 |
Why?
| | Leishmaniasis | 1 | 2010 | 2 | 0.080 |
Why?
| | Tongue Diseases | 1 | 2010 | 6 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2012 | 1045 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3449 | 0.070 |
Why?
| | Child, Preschool | 1 | 2013 | 4046 | 0.060 |
Why?
| | Societies, Medical | 1 | 2025 | 200 | 0.050 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2016 | 26 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 151 | 0.030 |
Why?
| | United States | 1 | 2025 | 5215 | 0.030 |
Why?
| | Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 90 | 0.030 |
Why?
| | Insect Vectors | 1 | 2010 | 5 | 0.020 |
Why?
| | Psychodidae | 1 | 2010 | 2 | 0.020 |
Why?
| | Antiprotozoal Agents | 1 | 2010 | 8 | 0.020 |
Why?
| | Immunocompetence | 1 | 2010 | 18 | 0.020 |
Why?
| | Amphotericin B | 1 | 2010 | 104 | 0.020 |
Why?
| | Biopsy | 1 | 2010 | 594 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2014 | 2871 | 0.020 |
Why?
| | Animals | 1 | 2010 | 13485 | 0.010 |
Why?
|
|
Pandey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|